Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis Intervention: Drug: Geleli Sponsor: Peking University People's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials